Evidence map›Paper›PMID 34228362›Full record

ArticleCancer2021

What's new in pediatric melanoma and Spitz tumors? Pretty much everything.

Vernon K Sondak, Jane L Messina

Open access · bronzeAbstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Melanoma in Pediatric and Young Adult Patients.Current oncology reports · 2024
    Review
  3. Review
  4. Amelanotic malignant melanoma in a child.Anais brasileiros de dermatologia
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Vernon K SondakDepartment of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida.ORCID 0000-0003-1090-484X
Jane L MessinaDepartment of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida.
Moffitt Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

lay summaryPathologists sometimes have great difficulty in determining whether a mole biopsied from the skin of a child is benign or malignant. New molecular technologies have helped pathologists to identify pediatric melanomas, but there are still some atypical moles that cannot be definitively classified as benign or malignant. With further research, it is hoped that the number of these atypical tumors can be decreased and that the treatment for all children with moles and melanoma can be improved.

Indexed as

MelanomaNevus, Epithelioid and Spindle CellNevus, PigmentedSkin NeoplasmsChildHumansSkinatypical Spitz tumormelanomapediatricSpitz nevusSpitzoid melanoma

Identifiers

PMID34228362
OpenAlexW3177956578

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.